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Introduction
In Spain, 40% of the pacemaker (PM) implantations are performed by Intensive Care physicians [1] . In 1995, "The Cardiologic Intensive Care and Cardiopulmonary Resuscitation Section of The Spanish Society of Intensive Care, Critical and Coronary Units (GTCICyRCPSEMICYUC)" decided to create a database of all PM implants performed in the Intensive Care Units. This resulted in a pilot study and ended in the MAMI registration (MArcapasos definitivos en Medicina Intensiva) [2, 3] . The data have been presented at the annual meetings of the Cardiologic Intensive Care section and National society. Publication provides data up to December 31, 2010.
Initially, the data were entered into the database manually. Now, they are entered online with appropriate access codes at the following addresses: http://www.hospitaldonostia.org/mami or http:/ /www.donostiaospitalea.org/mami.
Methods
MAMI registration is an observational, prospective and multicenter study involving up to 50 Intensive Care Units in Spain. Not all of them have been reporting data over the years. Actually, at the moment there are 20 units that send records regularly. Every intervention performed in one of these Units creates a record that is sent to MAMI registration. Data are collected, processed and periodically presented at the annual meeting of the Society.
The variables included in the MAMI registration are: a) demographic and affiliation variables; b) etiology, symptoms, and ECG before implantation; c) type of intervention; d) lead and device location; e) electrical measurements at implant: capture threshold, intracardiac sensing and pacing impedance; f) lead and PM models and serial numbers; g) early complications (before hospital discharge).
The period of time covered by this registration began in April 1996 and patients are still being collected. This study reports data from the last 15 years, until December 31, 2010 and represents about 10% of fist implantations made in Spain.
The study was approved by the local research ethics committee and all patients were asked for written informed consent.
Statistical analysis
Records were collected in an Excel database (Microsoft ® ) and data were finally processed by SPSS 15.0 for Windows (2006) . Results are expressed mainly as percentage or proportions except for the age of patients which are expressed in years as means. One-way analysis of variance (ANOVA) was used to compare A wave measurements. Schaffé post hoc analysis was used to determine the group responsible for ANOVA statistical significance.
Results
During this period 31766 interventions were collected: 24643 (77.6%) first implants and 7123 (22.4%) replacements (Table 1) . Replacements were distributed as follows: battery 6094, battery and lead/s 665, and lead/s 248 (Table 2) .
Gender distribution is: 18226 (57.4%) men and 13540 (42.6%) women ( Table 1 ). The average age at first implant is 78.03 years and at replacement 78.55 years. The distribution of pacing mode is shown in Figure 1 .
In men average age at first implant is 77. (Fig. 2) . Figure 3 shows the age distribution of patients.
Most frequent symptoms at first implant are: syncope (39.3%), dizziness (27.5%) and heart failure (14.8%) ( Table 3) . Indication for replacement is mostly made by battery depletion (73.8%) ( Table 4) .
Electrical disorders at first implant were: atrio--ventricular block (AVB) 48.1%, atrial fibrillation (AF) 22.1%, sinus node disease (SND) 21% and bundle branch block (BBB) 4.2%. Table 5 shows complete information and gender distribution.
The most prevalent etiology registered is "conduction system fibrosis" (51.4%) ( Table 6 ).
The technique most commonly used for implantation of ventricular and atrial leads is puncture of the left subclavian vein. Subsequently, PM is usually located over the left pectoral muscle (80%) followed by the right pectoral muscle (17%). Distribution of pacing modes at first implant are: VVI(R) 47.2%, DDD(R) 31.3%, VDD(R) 20.1% and AAI(R) 1.1%. In replacement is similar: VVI(R) 49.2%, DDD(R) 31%, VDD(R) 18.4% and AAI(R) 1.2%. VDD pacing mode refers to single lead implantation pacemakers with floating sensors for A wave. No differences were registered by sex (Tables 7, 8 ).
The most prevalent pacing modes in patients with AVB and SND were VVI(R) followed by In Figure 6 temporal evolution of pacing modes from 1996 to 2010 is displayed divided by trienniums. VVI(R) shows a steady decrease from 52.2% to 44.6% and VDD(R) and DDD(R) a slight increase from 18.8% to 20.1% and 27.7% to 33.3%, respectively. AAI(R) is stable around 1.2%. There are no differences between men and women. Rate control algorithm is present in 45% of implanted devices. Muscular activity sensor is the most commonly used. See Table 9 for detailed information.
Electrical measures at first implant such as lead impedance, pacing threshold and intrinsic activity sensing are displayed in Table 10 . When atrial lead is implanted (AAI and DDD) the value of the sensed A wave is higher. With one way Pneumothorax, lead dislodgment and pocket hematoma were the most frequent complications. MAMI records mortality rate but not its cause.
Discussion
Pacemaker implantation is a continuously growing activity. In Spain in 1994 the rate of implantation was 270 U/10 6 inhabitants but in 2010 the rate has increased until 700 U/10 6 inhabitants (information source from manufacturers). Nevertheless rates of implants in Spain are far from those of Germany, France or USA which are about 1000 U/10 6 inhabitants. Part of this activity is carried out by intensive care physicians specialized in the management of these patients.
MAMI has proved effective showing data on PM implantation with the perspective of time. Analysis of the results will lead us to draw conclusions and raise new hypotheses [4, 5] . We now have data of 31766 interventions. MAMI is the largest registration ever published and only the National Danish Registration is comparable [6] .
Although some Units do not continuously send data, registration size and the wide geographical distribution of implanting units validate the results as representative of pacemaker implantation in Intensive Care Units in Spain.
Comparing MAMI data with international registrations no differences were found in first implantreplacement ratio neither in age, gender, complications and clinical situation leading to first implant [7, 8] .
However some differences should be highlighted: ECG prior to first implant in MAMI registration shows AVB in 48% of patients, AF 22%, SND 21% and BBB 4%. In Danish registration AVB is reported in 43% of patients, SND 35% and AF 15.4%. Differences in mode of pacing will be determined by these unequal proportions of ECG disorders.
In MAMI the most frequent etiological cause for the electrical disorder leading to PM implant is fibrosis of conduction system and automatism (51%). The unknown etiology is recorded in 28% of patients. In other registrations published the unknown etiology was prevalent. This difference can be explained by the consensus adopted in MAMI registration stating "fibrosis" to unknown etiology for ECG disorders in patients older than 75 years.
Nevertheless, the major difference among data lies on the distinct pacing modes selected for similar electrical disorders. Obviously in patients with AF VVI is the common election, but this consensus is not repeated any more with other electrical disorders [9] . This way, in Spain DDD(R) pacemakers are implanted in 38% of patients showing SND and AAI pacemakers just in 2%. In Denmark however [10] AAI pacing mode is programmed in 10% of patients, in Sweden 3.5%, Russia 8%, Lithuania 20%, Slovakia 4% [10, 11] . This is probably due to the low rate of progression to AVB in these countries which contrasts with the experience in others [12] .
In Spain, 24% of patients showing AVB are implanted with VDD devices and 38% with DDD whereas in Denmark these patients are almost exclusively DDD implanted. Reasons for these differences are not clear.
As we highlighted above MAMI registration is a good tool for chronological analysis of variables like age at first implant, pacing mode and ECG disorders. From 1996 to 2010 (Fig. 6 ) a decrease in VVI pacing mode from 52.2% to 44.6% has been recorded. On the other side we observed an increase in pacing modes that preserve AV synchrony from 48.8% to 54.7%. AAI maintains in 1.3%. These trends are equal for men and women. Unfortunately MAMI registration never included items for resynchronization pacing. We believe resynchronization therapy is a radical change in heart pacing for patients with low ejection fraction and wide QRS although probably the lion's share of the technique is reserved for implantable defibrillators. Figure 7 shows the evolution of rate control algorithm PM along the years. In Spain at present 82.4% of devices have this function. In Denmark 93% of devices are equipped with this function.
A sustained increase in the average age at first implant is registered in men as well as in women (76.13 to 78.27 in men; 77.93 to 80.14 in women) (Fig. 8) . Third grade AVB has shown a decrementing proportion as a main diagnosis for PM implantation. Second degree AVB, AF with low ventricular rate and SND have increased.
And finally, MAMI is to our knowledge the only registration that shows data of the electrical measures at implantation. Hence, we know that capture thresholds for ventricle and atrium are 0.5 and 0.8 V respectively with 0.5 ms impulse wide; V and P measures of 12 and 2 mV; pacing impedance 744 and 587 Ohms for ventricle and atrium. It is worthy to highlight that atrial sensing in VDD mode is clearly inferior to the measures obtained in AAI and DDD modes; this difference although predictable by the fact that in VDD mode there is no electrode directly implanted in atrial tissue (the electrode is floating in the atrium) had never been pointed out before in any registration. Anyway atrial sensing in VDD mode is most of the times good enough for a correct synchronous AV pacing.
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Conclusions
We can conclude that MAMI allows us to analyze chronologically the changes in PM implantation practice over the years. The evaluation of data collected in MAMI is very useful to understand the evolution of our practice and compare with registrations published by other groups and countries. 
